254 related articles for article (PubMed ID: 30208826)
1. Translation Factor eIF5A, Modification with Hypusine and Role in Regulation of Gene Expression. eIF5A as a Target for Pharmacological Interventions.
Turpaev KT
Biochemistry (Mosc); 2018 Aug; 83(8):863-873. PubMed ID: 30208826
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
Wolff EC; Kang KR; Kim YS; Park MH
Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
[TBL] [Abstract][Full Text] [Related]
3. Functional significance of eIF5A and its hypusine modification in eukaryotes.
Park MH; Nishimura K; Zanelli CF; Valentini SR
Amino Acids; 2010 Feb; 38(2):491-500. PubMed ID: 19997760
[TBL] [Abstract][Full Text] [Related]
4. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
[TBL] [Abstract][Full Text] [Related]
5. The translation factor eIF5A and human cancer.
Mathews MB; Hershey JW
Biochim Biophys Acta; 2015 Jul; 1849(7):836-44. PubMed ID: 25979826
[TBL] [Abstract][Full Text] [Related]
6. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
Kang KR; Kim YS; Wolff EC; Park MH
J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
[TBL] [Abstract][Full Text] [Related]
7. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
Park MH
J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
[TBL] [Abstract][Full Text] [Related]
8. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
Park MH; Kar RK; Banka S; Ziegler A; Chung WK
Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
[TBL] [Abstract][Full Text] [Related]
9. Hypusine, a polyamine-derived amino acid critical for eukaryotic translation.
Park MH; Wolff EC
J Biol Chem; 2018 Nov; 293(48):18710-18718. PubMed ID: 30257869
[TBL] [Abstract][Full Text] [Related]
10. Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins.
Nguyen S; Leija C; Kinch L; Regmi S; Li Q; Grishin NV; Phillips MA
J Biol Chem; 2015 Aug; 290(32):19987-98. PubMed ID: 26082486
[TBL] [Abstract][Full Text] [Related]
11. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of eukaryotic initiation factor 5A (eIF5A) by specific acetylation of its hypusine residue by spermidine/spermine acetyltransferase 1 (SSAT1).
Lee SB; Park JH; Folk JE; Deck JA; Pegg AE; Sokabe M; Fraser CS; Park MH
Biochem J; 2011 Jan; 433(1):205-13. PubMed ID: 20942800
[TBL] [Abstract][Full Text] [Related]
13. Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.
Ganapathi M; Padgett LR; Yamada K; Devinsky O; Willaert R; Person R; Au PB; Tagoe J; McDonald M; Karlowicz D; Wolf B; Lee J; Shen Y; Okur V; Deng L; LeDuc CA; Wang J; Hanner A; Mirmira RG; Park MH; Mastracci TL; Chung WK
Am J Hum Genet; 2019 Feb; 104(2):287-298. PubMed ID: 30661771
[TBL] [Abstract][Full Text] [Related]
14. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
Nakanishi S; Cleveland JL
Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
[TBL] [Abstract][Full Text] [Related]
15. The effect of hypusine modification on the intracellular localization of eIF5A.
Lee SB; Park JH; Kaevel J; Sramkova M; Weigert R; Park MH
Biochem Biophys Res Commun; 2009 Jun; 383(4):497-502. PubMed ID: 19379712
[TBL] [Abstract][Full Text] [Related]
16. Mutational analyses of human eIF5A-1--identification of amino acid residues critical for eIF5A activity and hypusine modification.
Cano VS; Jeon GA; Johansson HE; Henderson CA; Park JH; Valentini SR; Hershey JW; Park MH
FEBS J; 2008 Jan; 275(1):44-58. PubMed ID: 18067580
[TBL] [Abstract][Full Text] [Related]
17. The deoxyhypusine synthase mutant dys1-1 reveals the association of eIF5A and Asc1 with cell wall integrity.
Galvão FC; Rossi D; Silveira Wda S; Valentini SR; Zanelli CF
PLoS One; 2013; 8(4):e60140. PubMed ID: 23573236
[TBL] [Abstract][Full Text] [Related]
18. Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex.
Jao DL; Chen KY
J Cell Biochem; 2006 Feb; 97(3):583-98. PubMed ID: 16215987
[TBL] [Abstract][Full Text] [Related]
19. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
Fujimura K; Wright T; Strnadel J; Kaushal S; Metildi C; Lowy AM; Bouvet M; Kelber JA; Klemke RL
Cancer Res; 2014 Nov; 74(22):6671-81. PubMed ID: 25261239
[TBL] [Abstract][Full Text] [Related]
20. Amino acid substrates impose polyamine, eIF5A, or hypusine requirement for peptide synthesis.
Shin BS; Katoh T; Gutierrez E; Kim JR; Suga H; Dever TE
Nucleic Acids Res; 2017 Aug; 45(14):8392-8402. PubMed ID: 28637321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]